Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade Toripalimab | Login | Research Grade Toripalimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Budigalimab | Login | Research Grade Budigalimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Camrelizumab | Login | Research Grade Camrelizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Lodapolimab | Login | Research Grade Lodapolimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Serplulimab | Login | Research Grade Serplulimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Spartalizumab | Login | Research Grade Spartalizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Pidilizumab | Login | Research Grade Pidilizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Prolgolimab | Login | Research Grade Prolgolimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Retifanlimab | Login | Research Grade Retifanlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Sasanlimab | Login | Research Grade Sasanlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ezabenlimab | Login | Research Grade Ezabenlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Olinvacimab | Login | Research Grade Olinvacimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Alacizumab | Login | Research Grade Alacizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tanibirumab | Login | Research Grade Tanibirumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vulinacimab | Login | Research Grade Vulinacimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Azintuxizumab | Login | Research Grade Azintuxizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Citatuzumab | Login | Research Grade Citatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Edrecolomab | Login | Research Grade Edrecolomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Oportuzumab | Login | Research Grade Oportuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Solitomab | Login | Research Grade Solitomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Bemarituzumab | Login | Research Grade Bemarituzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Aprutumab | Login | Research Grade Aprutumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vofatamab | Login | Research Grade Vofatamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Disitamab | Login | Research Grade Disitamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Timigutuzumab | Login | Research Grade Timigutuzumab | ||||||||||||||||
|
||||||||||||||||||


